G-FINDER , an initiative of Policy Cures Research which reports on global health research and development (R&D), has released its 12th annual report, synthesizing data from 2018. The report's data is based on a yearly survey of major funders and developers in the global health R&D sector.
Central findings of the report include:
- Funding for tools combatting neglected diseases topped US$4 billion-- the highest on record;
- Global funding for neglected disease R&D increased by US$290 million in 2018, or 7.9%-- the largest funding increase on record and the first time ever that funding increased for three years consecutively;
- Despite record growth in other areas, funding for the WHO neglected tropical diseases has barely increased over the last decade;
- HIV/AIDS, malaria, and tuberculosis (TB) received over two-thirds of all global funding for neglected disease R&D in 2018 (US$2.8 billion, or 69%); and
- Despite record investment levels (US$2.6 billion), the public sector's share of total funding fell to its lowest ever, due to strong growth from private sector donors.